Request for Covid-19 Impact Assessment of this Report
Painkillers only: Only a simple analgesic effect, but no anti-inflammatory function, such as acetaminophen, tramadol. Acetaminophen side effects, but the analgesic effect is relatively weak, mainly for mild to moderate pain; tramadol analgesic effect is strong, but also side effects are larger, mainly gastrointestinal side effects such as nausea, vomiting and so on.
NSAIDs: With both anti-inflammatory and analgesic effect, suitable for inflammatory pain, for the acute phase of osteoarthritis, joint swelling of the patients to relieve symptoms better. These drugs may lead to nausea, vomiting and other gastrointestinal discomfort, but also increase the risk of gastrointestinal bleeding, so patients with gastro duodenal ulcer in the application of these drugs should consult a digestive physician, plus gastric mucosal protection Drugs or antacid drugs.
Medicines for Osteoarthritis Pain are available as pills, syrups, creams or lotions, or they are injected into a joint.
Scope of the Report:
This report focuses on the Osteoarthritis Pain Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Osteoarthritis, the most common type of arthritis, is a leading cause of disability. It is a chronic, progressive degenerative joint disease, which is characterized by gradual destruction of the articular cartilage, hypertrophy of the bone margins, and a series of biochemical and morphological changes in the synovial membrane and joint capsule. This results in pain and loss of movement.
The USA osteoarthritis pain drugs market is very concerted market; the revenue of eleven manufacturers accounts about 88% of the total revenue in 2016. The high-end products mainly come from USA and Europe.
The leading manufactures mainly are Johnson & Johnson, Pfizer and GlaxoSmithKline. Johnson & Johnson is the largest manufacturer; its revenue of USA market exceeds 27% in 2016. The next is Pfizer and GlaxoSmithKline.
The worldwide market for Osteoarthritis Pain Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Johnson & Johnson
Pfizer
GlaxoSmithKline
Mylan
Lilly
Sanofi
Abbott Laboratories
Bayer
Almatica Pharma
TEVA
Iroko Pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Oral
Injection
External
Market Segment by Applications, can be divided into
Medical Care
Personal Care
There are 15 Chapters to deeply display the global Osteoarthritis Pain Drugs market.
Chapter 1, to describe Osteoarthritis Pain Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Osteoarthritis Pain Drugs, with sales, revenue, and price of Osteoarthritis Pain Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Osteoarthritis Pain Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Osteoarthritis Pain Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Osteoarthritis Pain Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
1 Market Overview
1.1 Osteoarthritis Pain Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Oral
1.2.2 Injection
1.2.3 External
1.3 Market Analysis by Applications
1.3.1 Medical Care
1.3.2 Personal Care
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Johnson & Johnson
2.1.1 Business Overview
2.1.1.1 Johnson & Johnson Description
2.1.1.2 Johnson & Johnson Headquarter, Main Business and Finance Overview
2.1.2 Johnson & Johnson Osteoarthritis Pain Drugs Product Introduction
2.1.2.1 Osteoarthritis Pain Drugs Production Bases, Sales Regions and Major Competitors
2.1.2.2 Osteoarthritis Pain Drugs Product Information
2.1.3 Johnson & Johnson Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Johnson & Johnson Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Johnson & Johnson Osteoarthritis Pain Drugs Market Share in 2017
2.2 Pfizer
2.2.1 Business Overview
2.2.1.1 Pfizer Description
2.2.1.2 Pfizer Headquarter, Main Business and Finance Overview
2.2.2 Pfizer Osteoarthritis Pain Drugs Product Introduction
2.2.2.1 Osteoarthritis Pain Drugs Production Bases, Sales Regions and Major Competitors
2.2.2.2 Osteoarthritis Pain Drugs Product Information
2.2.3 Pfizer Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Pfizer Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Pfizer Osteoarthritis Pain Drugs Market Share in 2017
2.3 GlaxoSmithKline
2.3.1 Business Overview
2.3.1.1 GlaxoSmithKline Description
2.3.1.2 GlaxoSmithKline Headquarter, Main Business and Finance Overview
2.3.2 GlaxoSmithKline Osteoarthritis Pain Drugs Product Introduction
2.3.2.1 Osteoarthritis Pain Drugs Production Bases, Sales Regions and Major Competitors
2.3.2.2 Osteoarthritis Pain Drugs Product Information
2.3.3 GlaxoSmithKline Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 GlaxoSmithKline Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global GlaxoSmithKline Osteoarthritis Pain Drugs Market Share in 2017
2.4 Mylan
2.4.1 Business Overview
2.4.1.1 Mylan Description
2.4.1.2 Mylan Headquarter, Main Business and Finance Overview
2.4.2 Mylan Osteoarthritis Pain Drugs Product Introduction
2.4.2.1 Osteoarthritis Pain Drugs Production Bases, Sales Regions and Major Competitors
2.4.2.2 Osteoarthritis Pain Drugs Product Information
2.4.3 Mylan Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Mylan Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Mylan Osteoarthritis Pain Drugs Market Share in 2017
2.5 Lilly
2.5.1 Business Overview
2.5.1.1 Lilly Description
2.5.1.2 Lilly Headquarter, Main Business and Finance Overview
2.5.2 Lilly Osteoarthritis Pain Drugs Product Introduction
2.5.2.1 Osteoarthritis Pain Drugs Production Bases, Sales Regions and Major Competitors
2.5.2.2 Osteoarthritis Pain Drugs Product Information
2.5.3 Lilly Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Lilly Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Lilly Osteoarthritis Pain Drugs Market Share in 2017
2.6 Sanofi
2.6.1 Business Overview
2.6.1.1 Sanofi Description
2.6.1.2 Sanofi Headquarter, Main Business and Finance Overview
2.6.2 Sanofi Osteoarthritis Pain Drugs Product Introduction
2.6.2.1 Osteoarthritis Pain Drugs Production Bases, Sales Regions and Major Competitors
2.6.2.2 Osteoarthritis Pain Drugs Product Information
2.6.3 Sanofi Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Sanofi Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Sanofi Osteoarthritis Pain Drugs Market Share in 2017
2.7 Abbott Laboratories
2.7.1 Business Overview
2.7.1.1 Abbott Laboratories Description
2.7.1.2 Abbott Laboratories Headquarter, Main Business and Finance Overview
2.7.2 Abbott Laboratories Osteoarthritis Pain Drugs Product Introduction
2.7.2.1 Osteoarthritis Pain Drugs Production Bases, Sales Regions and Major Competitors
2.7.2.2 Osteoarthritis Pain Drugs Product Information
2.7.3 Abbott Laboratories Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Abbott Laboratories Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Abbott Laboratories Osteoarthritis Pain Drugs Market Share in 2017
2.8 Bayer
2.8.1 Business Overview
2.8.1.1 Bayer Description
2.8.1.2 Bayer Headquarter, Main Business and Finance Overview
2.8.2 Bayer Osteoarthritis Pain Drugs Product Introduction
2.8.2.1 Osteoarthritis Pain Drugs Production Bases, Sales Regions and Major Competitors
2.8.2.2 Osteoarthritis Pain Drugs Product Information
2.8.3 Bayer Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Bayer Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Bayer Osteoarthritis Pain Drugs Market Share in 2017
2.9 Almatica Pharma
2.9.1 Business Overview
2.9.1.1 Almatica Pharma Description
2.9.1.2 Almatica Pharma Headquarter, Main Business and Finance Overview
2.9.2 Almatica Pharma Osteoarthritis Pain Drugs Product Introduction
2.9.2.1 Osteoarthritis Pain Drugs Production Bases, Sales Regions and Major Competitors
2.9.2.2 Osteoarthritis Pain Drugs Product Information
2.9.3 Almatica Pharma Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 Almatica Pharma Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global Almatica Pharma Osteoarthritis Pain Drugs Market Share in 2017
2.10 TEVA
2.10.1 Business Overview
2.10.1.1 TEVA Description
2.10.1.2 TEVA Headquarter, Main Business and Finance Overview
2.10.2 TEVA Osteoarthritis Pain Drugs Product Introduction
2.10.2.1 Osteoarthritis Pain Drugs Production Bases, Sales Regions and Major Competitors
2.10.2.2 Osteoarthritis Pain Drugs Product Information
2.10.3 TEVA Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 TEVA Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global TEVA Osteoarthritis Pain Drugs Market Share in 2017
2.11 Iroko Pharmaceuticals
2.11.1 Business Overview
2.11.2 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Product Introduction
2.11.3 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Osteoarthritis Pain Drugs Market Competition, by Manufacturer
3.1 Global Osteoarthritis Pain Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Osteoarthritis Pain Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Osteoarthritis Pain Drugs Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Osteoarthritis Pain Drugs Manufacturer Market Share in 2017
3.4.2 Top 5 Osteoarthritis Pain Drugs Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Osteoarthritis Pain Drugs Market Analysis by Regions
4.1 Global Osteoarthritis Pain Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Osteoarthritis Pain Drugs Sales by Regions (2013-2018)
4.1.2 Global Osteoarthritis Pain Drugs Revenue by Regions (2013-2018)
4.2 North America Osteoarthritis Pain Drugs Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Osteoarthritis Pain Drugs Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Osteoarthritis Pain Drugs Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Osteoarthritis Pain Drugs Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Osteoarthritis Pain Drugs Sales, Revenue and Growth Rate (2013-2018)
5 North America Osteoarthritis Pain Drugs by Countries, Type, Application and Manufacturers
5.1 North America Osteoarthritis Pain Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Osteoarthritis Pain Drugs Sales by Countries (2013-2018)
5.1.2 North America Osteoarthritis Pain Drugs Revenue by Countries (2013-2018)
5.1.3 United States Osteoarthritis Pain Drugs Sales and Growth Rate (2013-2018)
5.1.4 Canada Osteoarthritis Pain Drugs Sales and Growth Rate (2013-2018)
5.1.5 Mexico Osteoarthritis Pain Drugs Sales and Growth Rate (2013-2018)
5.2 North America Osteoarthritis Pain Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Osteoarthritis Pain Drugs Sales by Manufacturers (2016-2017)
5.2.2 North America Osteoarthritis Pain Drugs Revenue by Manufacturers (2016-2017)
5.3 North America Osteoarthritis Pain Drugs Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Osteoarthritis Pain Drugs Sales and Sales Share by Type (2013-2018)
5.3.2 North America Osteoarthritis Pain Drugs Revenue and Revenue Share by Type (2013-2018)
5.4 North America Osteoarthritis Pain Drugs Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Osteoarthritis Pain Drugs Sales and Sales Share by Application (2013-2018)
5.4.2 North America Osteoarthritis Pain Drugs Revenue and Revenue Share by Application (2013-2018)
6 Europe Osteoarthritis Pain Drugs by Countries, Type, Application and Manufacturers
6.1 Europe Osteoarthritis Pain Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Osteoarthritis Pain Drugs Sales by Countries (2013-2018)
6.1.2 Europe Osteoarthritis Pain Drugs Revenue by Countries (2013-2018)
6.1.3 Germany Osteoarthritis Pain Drugs Sales and Growth Rate (2013-2018)
6.1.4 UK Osteoarthritis Pain Drugs Sales and Growth Rate (2013-2018)
6.1.5 France Osteoarthritis Pain Drugs Sales and Growth Rate (2013-2018)
6.1.6 Russia Osteoarthritis Pain Drugs Sales and Growth Rate (2013-2018)
6.1.7 Italy Osteoarthritis Pain Drugs Sales and Growth Rate (2013-2018)
6.2 Europe Osteoarthritis Pain Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Osteoarthritis Pain Drugs Sales by Manufacturers (2016-2017)
6.2.2 Europe Osteoarthritis Pain Drugs Revenue by Manufacturers (2016-2017)
6.3 Europe Osteoarthritis Pain Drugs Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Osteoarthritis Pain Drugs Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Osteoarthritis Pain Drugs Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Osteoarthritis Pain Drugs Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Osteoarthritis Pain Drugs Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Osteoarthritis Pain Drugs Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Osteoarthritis Pain Drugs by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Osteoarthritis Pain Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Osteoarthritis Pain Drugs Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Osteoarthritis Pain Drugs Revenue by Countries (2013-2018)
7.1.3 China Osteoarthritis Pain Drugs Sales and Growth Rate (2013-2018)
7.1.4 Japan Osteoarthritis Pain Drugs Sales and Growth Rate (2013-2018)
7.1.5 Korea Osteoarthritis Pain Drugs Sales and Growth Rate (2013-2018)
7.1.6 India Osteoarthritis Pain Drugs Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Osteoarthritis Pain Drugs Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Osteoarthritis Pain Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Osteoarthritis Pain Drugs Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Osteoarthritis Pain Drugs Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Osteoarthritis Pain Drugs Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Osteoarthritis Pain Drugs Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Osteoarthritis Pain Drugs Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Osteoarthritis Pain Drugs Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Osteoarthritis Pain Drugs Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Osteoarthritis Pain Drugs Revenue and Revenue Share by Application (2013-2018)
8 South America Osteoarthritis Pain Drugs by Countries, Type, Application and Manufacturers
8.1 South America Osteoarthritis Pain Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Osteoarthritis Pain Drugs Sales by Countries (2013-2018)
8.1.2 South America Osteoarthritis Pain Drugs Revenue by Countries (2013-2018)
8.1.3 Brazil Osteoarthritis Pain Drugs Sales and Growth Rate (2013-2018)
8.1.4 Argentina Osteoarthritis Pain Drugs Sales and Growth Rate (2013-2018)
8.1.5 Colombia Osteoarthritis Pain Drugs Sales and Growth Rate (2013-2018)
8.2 South America Osteoarthritis Pain Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Osteoarthritis Pain Drugs Sales by Manufacturers (2016-2017)
8.2.2 South America Osteoarthritis Pain Drugs Revenue by Manufacturers (2016-2017)
8.3 South America Osteoarthritis Pain Drugs Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Osteoarthritis Pain Drugs Sales and Sales Share by Type (2013-2018)
8.3.2 South America Osteoarthritis Pain Drugs Revenue and Revenue Share by Type (2013-2018)
8.4 South America Osteoarthritis Pain Drugs Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Osteoarthritis Pain Drugs Sales and Sales Share by Application (2013-2018)
8.4.2 South America Osteoarthritis Pain Drugs Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Osteoarthritis Pain Drugs by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Osteoarthritis Pain Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Osteoarthritis Pain Drugs Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Osteoarthritis Pain Drugs Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Osteoarthritis Pain Drugs Sales and Growth Rate (2013-2018)
9.1.4 UAE Osteoarthritis Pain Drugs Sales and Growth Rate (2013-2018)
9.1.5 Egypt Osteoarthritis Pain Drugs Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Osteoarthritis Pain Drugs Sales and Growth Rate (2013-2018)
9.1.7 South Africa Osteoarthritis Pain Drugs Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Osteoarthritis Pain Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Osteoarthritis Pain Drugs Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Osteoarthritis Pain Drugs Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Osteoarthritis Pain Drugs Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Osteoarthritis Pain Drugs Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Osteoarthritis Pain Drugs Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Osteoarthritis Pain Drugs Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Osteoarthritis Pain Drugs Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Osteoarthritis Pain Drugs Revenue and Revenue Share by Application (2013-2018)
10 Global Osteoarthritis Pain Drugs Market Segment by Type
10.1 Global Osteoarthritis Pain Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Osteoarthritis Pain Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Osteoarthritis Pain Drugs Revenue and Market Share by Type (2013-2018)
10.2 Oral Sales Growth and Price
10.2.1 Global Oral Sales Growth (2013-2018)
10.2.2 Global Oral Price (2013-2018)
10.3 Injection Sales Growth and Price
10.3.1 Global Injection Sales Growth (2013-2018)
10.3.2 Global Injection Price (2013-2018)
10.4 External Sales Growth and Price
10.4.1 Global External Sales Growth (2013-2018)
10.4.2 Global External Price (2013-2018)
11 Global Osteoarthritis Pain Drugs Market Segment by Application
11.1 Global Osteoarthritis Pain Drugs Sales Market Share by Application (2013-2018)
11.2 Medical Care Sales Growth (2013-2018)
11.3 Personal Care Sales Growth (2013-2018)
12 Osteoarthritis Pain Drugs Market Forecast (2018-2023)
12.1 Global Osteoarthritis Pain Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Osteoarthritis Pain Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Osteoarthritis Pain Drugs Market Forecast (2018-2023)
12.2.2 Europe Osteoarthritis Pain Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Osteoarthritis Pain Drugs Market Forecast (2018-2023)
12.2.4 South America Osteoarthritis Pain Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Osteoarthritis Pain Drugs Market Forecast (2018-2023)
12.3 Osteoarthritis Pain Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Osteoarthritis Pain Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Osteoarthritis Pain Drugs Market Share Forecast by Type (2018-2023)
12.4 Osteoarthritis Pain Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Osteoarthritis Pain Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Osteoarthritis Pain Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Osteoarthritis Pain Drugs Picture
Table Product Specifications of Osteoarthritis Pain Drugs
Figure Global Osteoarthritis Pain Drugs CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Osteoarthritis Pain Drugs CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Osteoarthritis Pain Drugs by Types in 2017
Figure Oral Picture
Table Major Manufacturers of Oral
Figure Injection Picture
Table Major Manufacturers of Injection
Figure External Picture
Table Major Manufacturers of External
Figure Osteoarthritis Pain Drugs Sales Market Share by Applications in 2017
Figure Medical Care Picture
Figure Personal Care Picture
Figure United States Osteoarthritis Pain Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Osteoarthritis Pain Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Osteoarthritis Pain Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Osteoarthritis Pain Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure France Osteoarthritis Pain Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure UK Osteoarthritis Pain Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Osteoarthritis Pain Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Osteoarthritis Pain Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure China Osteoarthritis Pain Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Osteoarthritis Pain Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Osteoarthritis Pain Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure India Osteoarthritis Pain Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Osteoarthritis Pain Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Osteoarthritis Pain Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Osteoarthritis Pain Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Osteoarthritis Pain Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Osteoarthritis Pain Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Osteoarthritis Pain Drugs Revenue (Value) and Growth Rate (2013-2023)
Table Johnson & Johnson Headquarter, Established, Main Business and Finance Overview (2017)
Table Johnson & Johnson Osteoarthritis Pain Drugs Production Bases, Sales Regions and Major Competitors
Table Johnson & Johnson Osteoarthritis Pain Drugs Product
Table Johnson & Johnson Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Johnson & Johnson Osteoarthritis Pain Drugs Sales Market Share in 2017
Figure Global Johnson & Johnson Osteoarthritis Pain Drugs Revenue Market Share in 2017
Table Pfizer Headquarter, Established, Main Business and Finance Overview (2017)
Table Pfizer Osteoarthritis Pain Drugs Production Bases, Sales Regions and Major Competitors
Table Pfizer Osteoarthritis Pain Drugs Product
Table Pfizer Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Pfizer Osteoarthritis Pain Drugs Sales Market Share in 2017
Figure Global Pfizer Osteoarthritis Pain Drugs Revenue Market Share in 2017
Table GlaxoSmithKline Headquarter, Established, Main Business and Finance Overview (2017)
Table GlaxoSmithKline Osteoarthritis Pain Drugs Production Bases, Sales Regions and Major Competitors
Table GlaxoSmithKline Osteoarthritis Pain Drugs Product
Table GlaxoSmithKline Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global GlaxoSmithKline Osteoarthritis Pain Drugs Sales Market Share in 2017
Figure Global GlaxoSmithKline Osteoarthritis Pain Drugs Revenue Market Share in 2017
Table Mylan Headquarter, Established, Main Business and Finance Overview (2017)
Table Mylan Osteoarthritis Pain Drugs Production Bases, Sales Regions and Major Competitors
Table Mylan Osteoarthritis Pain Drugs Product
Table Mylan Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Mylan Osteoarthritis Pain Drugs Sales Market Share in 2017
Figure Global Mylan Osteoarthritis Pain Drugs Revenue Market Share in 2017
Table Lilly Headquarter, Established, Main Business and Finance Overview (2017)
Table Lilly Osteoarthritis Pain Drugs Production Bases, Sales Regions and Major Competitors
Table Lilly Osteoarthritis Pain Drugs Product
Table Lilly Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Lilly Osteoarthritis Pain Drugs Sales Market Share in 2017
Figure Global Lilly Osteoarthritis Pain Drugs Revenue Market Share in 2017
Table Sanofi Headquarter, Established, Main Business and Finance Overview (2017)
Table Sanofi Osteoarthritis Pain Drugs Production Bases, Sales Regions and Major Competitors
Table Sanofi Osteoarthritis Pain Drugs Product
Table Sanofi Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Sanofi Osteoarthritis Pain Drugs Sales Market Share in 2017
Figure Global Sanofi Osteoarthritis Pain Drugs Revenue Market Share in 2017
Table Abbott Laboratories Headquarter, Established, Main Business and Finance Overview (2017)
Table Abbott Laboratories Osteoarthritis Pain Drugs Production Bases, Sales Regions and Major Competitors
Table Abbott Laboratories Osteoarthritis Pain Drugs Product
Table Abbott Laboratories Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Abbott Laboratories Osteoarthritis Pain Drugs Sales Market Share in 2017
Figure Global Abbott Laboratories Osteoarthritis Pain Drugs Revenue Market Share in 2017
Table Bayer Headquarter, Established, Main Business and Finance Overview (2017)
Table Bayer Osteoarthritis Pain Drugs Production Bases, Sales Regions and Major Competitors
Table Bayer Osteoarthritis Pain Drugs Product
Table Bayer Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Bayer Osteoarthritis Pain Drugs Sales Market Share in 2017
Figure Global Bayer Osteoarthritis Pain Drugs Revenue Market Share in 2017
Table Almatica Pharma Headquarter, Established, Main Business and Finance Overview (2017)
Table Almatica Pharma Osteoarthritis Pain Drugs Production Bases, Sales Regions and Major Competitors
Table Almatica Pharma Osteoarthritis Pain Drugs Product
Table Almatica Pharma Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Almatica Pharma Osteoarthritis Pain Drugs Sales Market Share in 2017
Figure Global Almatica Pharma Osteoarthritis Pain Drugs Revenue Market Share in 2017
Table TEVA Headquarter, Established, Main Business and Finance Overview (2017)
Table TEVA Osteoarthritis Pain Drugs Production Bases, Sales Regions and Major Competitors
Table TEVA Osteoarthritis Pain Drugs Product
Table TEVA Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global TEVA Osteoarthritis Pain Drugs Sales Market Share in 2017
Figure Global TEVA Osteoarthritis Pain Drugs Revenue Market Share in 2017
Table Iroko Pharmaceuticals
Table Iroko Pharmaceuticals Osteoarthritis Pain Drugs
Table Global Osteoarthritis Pain Drugs Sales by Manufacturer (2016-2017)
Figure Global Osteoarthritis Pain Drugs Sales Market Share by Manufacturer in 2016
Figure Global Osteoarthritis Pain Drugs Sales Market Share by Manufacturer in 2017
Table Global Osteoarthritis Pain Drugs Revenue by Manufacturer (2016-2017)
Figure Global Osteoarthritis Pain Drugs Revenue Market Share by Manufacturer in 2016
Figure Global Osteoarthritis Pain Drugs Revenue Market Share by Manufacturer in 2017
Table Global Osteoarthritis Pain Drugs Price by Manufacturer (2016-2017)
Figure Top 3 Osteoarthritis Pain Drugs Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Osteoarthritis Pain Drugs Manufacturer (Revenue) Market Share in 2017
Figure Global Osteoarthritis Pain Drugs Sales and Growth Rate (2013-2018)
Figure Global Osteoarthritis Pain Drugs Revenue and Growth Rate (2013-2018)
Table Global Osteoarthritis Pain Drugs Sales by Regions (2013-2018)
Table Global Osteoarthritis Pain Drugs Sales Market Share by Regions (2013-2018)
Table Global Osteoarthritis Pain Drugs Revenue by Regions (2013-2018)
Figure Global Osteoarthritis Pain Drugs Revenue Market Share by Regions in 2013
Figure Global Osteoarthritis Pain Drugs Revenue Market Share by Regions in 2017
Figure North America Osteoarthritis Pain Drugs Sales and Growth Rate (2013-2018)
Figure North America Osteoarthritis Pain Drugs Revenue and Growth Rate (2013-2018)
Figure Europe Osteoarthritis Pain Drugs Sales and Growth Rate (2013-2018)
Figure Europe Osteoarthritis Pain Drugs Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Osteoarthritis Pain Drugs Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Osteoarthritis Pain Drugs Revenue and Growth Rate (2013-2018)
Figure South America Osteoarthritis Pain Drugs Sales and Growth Rate (2013-2018)
Figure South America Osteoarthritis Pain Drugs Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Osteoarthritis Pain Drugs Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Osteoarthritis Pain Drugs Revenue and Growth Rate (2013-2018)
Figure North America Osteoarthritis Pain Drugs Revenue and Growth Rate (2013-2018)
Table North America Osteoarthritis Pain Drugs Sales by Countries (2013-2018)
Table North America Osteoarthritis Pain Drugs Sales Market Share by Countries (2013-2018)
Figure North America Osteoarthritis Pain Drugs Sales Market Share by Countries in 2013
Figure North America Osteoarthritis Pain Drugs Sales Market Share by Countries in 2017
Table North America Osteoarthritis Pain Drugs Revenue by Countries (2013-2018)
Table North America Osteoarthritis Pain Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Osteoarthritis Pain Drugs Revenue Market Share by Countries in 2013
Figure North America Osteoarthritis Pain Drugs Revenue Market Share by Countries in 2017
Figure United States Osteoarthritis Pain Drugs Sales and Growth Rate (2013-2018)
Figure Canada Osteoarthritis Pain Drugs Sales and Growth Rate (2013-2018)
Figure Mexico Osteoarthritis Pain Drugs Sales and Growth Rate (2013-2018)
Table North America Osteoarthritis Pain Drugs Sales by Manufacturer (2016-2017)
Figure North America Osteoarthritis Pain Drugs Sales Market Share by Manufacturer in 2016
Figure North America Osteoarthritis Pain Drugs Sales Market Share by Manufacturer in 2017
Table North America Osteoarthritis Pain Drugs Revenue by Manufacturer (2016-2017)
Figure North America Osteoarthritis Pain Drugs Revenue Market Share by Manufacturer in 2016
Figure North America Osteoarthritis Pain Drugs Revenue Market Share by Manufacturer in 2017
Table North America Osteoarthritis Pain Drugs Sales by Type (2013-2018)
Table North America Osteoarthritis Pain Drugs Sales Share by Type (2013-2018)
Table North America Osteoarthritis Pain Drugs Revenue by Type (2013-2018)
Table North America Osteoarthritis Pain Drugs Revenue Share by Type (2013-2018)
Table North America Osteoarthritis Pain Drugs Sales by Application (2013-2018)
Table North America Osteoarthritis Pain Drugs Sales Share by Application (2013-2018)
Table North America Osteoarthritis Pain Drugs Revenue by Application (2013-2018)
Table North America Osteoarthritis Pain Drugs Revenue Share by Application (2013-2018)
Figure Europe Osteoarthritis Pain Drugs Revenue and Growth Rate (2013-2018)
Table Europe Osteoarthritis Pain Drugs Sales by Countries (2013-2018)
Table Europe Osteoarthritis Pain Drugs Sales Market Share by Countries (2013-2018)
Table Europe Osteoarthritis Pain Drugs Revenue by Countries (2013-2018)
Figure Europe Osteoarthritis Pain Drugs Revenue Market Share by Countries in 2016
Figure Europe Osteoarthritis Pain Drugs Revenue Market Share by Countries in 2017
Figure Germany Osteoarthritis Pain Drugs Sales and Growth Rate (2013-2018)
Figure UK Osteoarthritis Pain Drugs Sales and Growth Rate (2013-2018)
Figure France Osteoarthritis Pain Drugs Sales and Growth Rate (2013-2018)
Figure Russia Osteoarthritis Pain Drugs Sales and Growth Rate (2013-2018)
Figure Italy Osteoarthritis Pain Drugs Sales and Growth Rate (2013-2018)
Table Europe Osteoarthritis Pain Drugs Sales by Manufacturer (2016-2017)
Figure Europe Osteoarthritis Pain Drugs Sales Market Share by Manufacturer in 2016
Figure Europe Osteoarthritis Pain Drugs Sales Market Share by Manufacturer in 2017
Table Europe Osteoarthritis Pain Drugs Revenue by Manufacturer (2016-2017)
Figure Europe Osteoarthritis Pain Drugs Revenue Market Share by Manufacturer in 2016
Figure Europe Osteoarthritis Pain Drugs Revenue Market Share by Manufacturer in 2017
Table Europe Osteoarthritis Pain Drugs Sales by Type (2013-2018)
Table Europe Osteoarthritis Pain Drugs Sales Share by Type (2013-2018)
Table Europe Osteoarthritis Pain Drugs Revenue by Type (2013-2018)
Table Europe Osteoarthritis Pain Drugs Revenue Share by Type (2013-2018)
Table Europe Osteoarthritis Pain Drugs Sales by Application (2013-2018)
Table Europe Osteoarthritis Pain Drugs Sales Share by Application (2013-2018)
Table Europe Osteoarthritis Pain Drugs Revenue by Application (2013-2018)
Table Europe Osteoarthritis Pain Drugs Revenue Share by Application (2013-2018)
Figure Asia-Pacific Osteoarthritis Pain Drugs Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Osteoarthritis Pain Drugs Sales by Countries (2013-2018)
Table Asia-Pacific Osteoarthritis Pain Drugs Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Osteoarthritis Pain Drugs Sales Market Share by Countries 2017
Table Asia-Pacific Osteoarthritis Pain Drugs Revenue by Countries (2013-2018)
Figure Asia-Pacific Osteoarthritis Pain Drugs Revenue Market Share by Countries 2017
Figure China Osteoarthritis Pain Drugs Sales and Growth Rate (2013-2018)
Figure Japan Osteoarthritis Pain Drugs Sales and Growth Rate (2013-2018)
Figure Korea Osteoarthritis Pain Drugs Sales and Growth Rate (2013-2018)
Figure India Osteoarthritis Pain Drugs Sales and Growth Rate (2013-2018)
Figure Southeast Asia Osteoarthritis Pain Drugs Sales and Growth Rate (2013-2018)
Table Asia-Pacific Osteoarthritis Pain Drugs Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Osteoarthritis Pain Drugs Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Osteoarthritis Pain Drugs Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Osteoarthritis Pain Drugs Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Osteoarthritis Pain Drugs Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Osteoarthritis Pain Drugs Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Osteoarthritis Pain Drugs Sales by Type (2013-2018)
Table Asia-Pacific Osteoarthritis Pain Drugs Sales Share by Type (2013-2018)
Table Asia-Pacific Osteoarthritis Pain Drugs Revenue by Type (2013-2018)
Table Asia-Pacific Osteoarthritis Pain Drugs Revenue Share by Type (2013-2018)
Table Asia-Pacific Osteoarthritis Pain Drugs Sales by Application (2013-2018)
Table Asia-Pacific Osteoarthritis Pain Drugs Sales Share by Application (2013-2018)
Table Asia-Pacific Osteoarthritis Pain Drugs Revenue by Application (2013-2018)
Table Asia-Pacific Osteoarthritis Pain Drugs Revenue Share by Application (2013-2018)
Figure South America Osteoarthritis Pain Drugs Revenue and Growth Rate (2013-2018)
Table South America Osteoarthritis Pain Drugs Sales by Countries (2013-2018)
Table South America Osteoarthritis Pain Drugs Sales Market Share by Countries (2013-2018)
Figure South America Osteoarthritis Pain Drugs Sales Market Share by Countries in 2017
Table South America Osteoarthritis Pain Drugs Revenue by Countries (2013-2018)
Table South America Osteoarthritis Pain Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Osteoarthritis Pain Drugs Revenue Market Share by Countries in 2017
Figure Brazil Osteoarthritis Pain Drugs Sales and Growth Rate (2013-2018)
Figure Argentina Osteoarthritis Pain Drugs Sales and Growth Rate (2013-2018)
Figure Colombia Osteoarthritis Pain Drugs Sales and Growth Rate (2013-2018)
Table South America Osteoarthritis Pain Drugs Sales by Manufacturer (2016-2017)
Figure South America Osteoarthritis Pain Drugs Sales Market Share by Manufacturer in 2016
Figure South America Osteoarthritis Pain Drugs Sales Market Share by Manufacturer in 2017
Table South America Osteoarthritis Pain Drugs Revenue by Manufacturer (2016-2017)
Figure South America Osteoarthritis Pain Drugs Revenue Market Share by Manufacturer in 2016
Figure South America Osteoarthritis Pain Drugs Revenue Market Share by Manufacturer in 2017
Table South America Osteoarthritis Pain Drugs Sales by Type (2013-2018)
Table South America Osteoarthritis Pain Drugs Sales Share by Type (2013-2018)
Table South America Osteoarthritis Pain Drugs Revenue by Type (2013-2018)
Table South America Osteoarthritis Pain Drugs Revenue Share by Type (2013-2018)
Table South America Osteoarthritis Pain Drugs Sales by Application (2013-2018)
Table South America Osteoarthritis Pain Drugs Sales Share by Application (2013-2018)
Table South America Osteoarthritis Pain Drugs Revenue by Application (2013-2018)
Table South America Osteoarthritis Pain Drugs Revenue Share by Application (2013-2018)
Figure Middle East and Africa Osteoarthritis Pain Drugs Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Osteoarthritis Pain Drugs Sales by Countries (2013-2018)
Table Middle East and Africa Osteoarthritis Pain Drugs Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Osteoarthritis Pain Drugs Sales Market Share by Countries in 2017
Table Middle East and Africa Osteoarthritis Pain Drugs Revenue by Countries (2013-2018)
Table Middle East and Africa Osteoarthritis Pain Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Osteoarthritis Pain Drugs Revenue Market Share by Countries in 2013
Figure Middle East and Africa Osteoarthritis Pain Drugs Revenue Market Share by Countries in 2017
Figure Saudi Arabia Osteoarthritis Pain Drugs Sales and Growth Rate (2013-2018)
Figure UAE Osteoarthritis Pain Drugs Sales and Growth Rate (2013-2018)
Figure Egypt Osteoarthritis Pain Drugs Sales and Growth Rate (2013-2018)
Figure Nigeria Osteoarthritis Pain Drugs Sales and Growth Rate (2013-2018)
Figure South Africa Osteoarthritis Pain Drugs Sales and Growth Rate (2013-2018)
Table Middle East and Africa Osteoarthritis Pain Drugs Sales by Manufacturer (2016-2017)
Figure Middle East and Africa Osteoarthritis Pain Drugs Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa Osteoarthritis Pain Drugs Sales Market Share by Manufacturer in 2017
Table Middle East and Africa Osteoarthritis Pain Drugs Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa Osteoarthritis Pain Drugs Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa Osteoarthritis Pain Drugs Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa Osteoarthritis Pain Drugs Sales by Type (2013-2018)
Table Middle East and Africa Osteoarthritis Pain Drugs Sales Share by Type (2013-2018)
Table Middle East and Africa Osteoarthritis Pain Drugs Revenue by Type (2013-2018)
Table Middle East and Africa Osteoarthritis Pain Drugs Revenue Share by Type (2013-2018)
Table Middle East and Africa Osteoarthritis Pain Drugs Sales by Application (2013-2018)
Table Middle East and Africa Osteoarthritis Pain Drugs Sales Share by Application (2013-2018)
Table Middle East and Africa Osteoarthritis Pain Drugs Revenue by Application (2013-2018)
Table Middle East and Africa Osteoarthritis Pain Drugs Revenue Share by Application (2013-2018)
Table Global Osteoarthritis Pain Drugs Sales by Type (2013-2018)
Table Global Osteoarthritis Pain Drugs Sales Share by Type (2013-2018)
Table Global Osteoarthritis Pain Drugs Revenue by Type (2013-2018)
Table Global Osteoarthritis Pain Drugs Revenue Share by Type (2013-2018)
Figure Global Oral Sales Growth (2013-2018)
Figure Global Oral Price (2013-2018)
Figure Global Injection Sales Growth (2013-2018)
Figure Global Injection Price (2013-2018)
Figure Global External Sales Growth (2013-2018)
Figure Global External Price (2013-2018)
Table Global Osteoarthritis Pain Drugs Sales by Application (2013-2018)
Table Global Osteoarthritis Pain Drugs Sales Share by Application (2013-2018)
Figure Global Medical Care Sales Growth (2013-2018)
Figure Global Personal Care Sales Growth (2013-2018)
Figure Global Osteoarthritis Pain Drugs Sales, Revenue and Growth Rate (2018-2023)
Table Global Osteoarthritis Pain Drugs Sales Forecast by Regions (2018-2023)
Table Global Osteoarthritis Pain Drugs Market Share Forecast by Regions (2018-2023)
Figure North America Sales Osteoarthritis Pain Drugs Market Forecast (2018-2023)
Figure Europe Sales Osteoarthritis Pain Drugs Market Forecast (2018-2023)
Figure Asia-Pacific Sales Osteoarthritis Pain Drugs Market Forecast (2018-2023)
Figure South America Sales Osteoarthritis Pain Drugs Market Forecast (2018-2023)
Figure Middle East and Africa Sales Osteoarthritis Pain Drugs Market Forecast (2018-2023)
Table Global Osteoarthritis Pain Drugs Sales Forecast by Type (2018-2023)
Table Global Osteoarthritis Pain Drugs Market Share Forecast by Type (2018-2023)
Table Global Osteoarthritis Pain Drugs Sales Forecast by Application (2018-2023)
Table Global Osteoarthritis Pain Drugs Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...